ARTICLE | Clinical News
Maintate bisoprolol fumarate regulatory update
June 24, 2013 7:00 AM UTC
Mitsubishi said Japan approved a regulatory application to expand the label of Maintate bisoprolol fumarate tablets to include treatment of atrial fibrillation. The selective adrenergic receptor beta...